Antithrombin Market Size, Share & Industry Analysis, By Source (Human Plasma and Others), By Application (Therapeutic and Research & Diagnostic), By Dosage Form (Lyophilized Powder and Liquid), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Industry, and Research Institutes), and Regional Forecast, 2026-2034

Last Updated: December 22, 2025 | Format: PDF | Report ID: FBI100470

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Cardiovascular Diseases, By Key Countries
2. Regulatory Scenario, By Key Countries
3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Approvals, Launches etc.)
4. Impact of COVID-19 on the Market
5. Overview: Antithrombin Market in Japan & South Korea
Global Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Germany
  2. UK
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. South Korea
  6. Southeast Asia
  7. Rest of Asia Pacific
Rest of World Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. CSL
  2. Octapharma AG
  3. Takeda Pharmaceutical Company Limited
  4. Grifols, S.A.
  5. Medix Biochemica
  6. Kedrion S.p.A.
  7. Scripps Laboratories
  8. LFB

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Cardiovascular Diseases, By Key Countries
2. Regulatory Scenario, By Key Countries
3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Approvals, Launches etc.)
4. Impact of COVID-19 on the Market
5. Overview: Antithrombin Market in Japan & South Korea
Global Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Germany
  2. UK
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. South Korea
  6. Southeast Asia
  7. Rest of Asia Pacific
Rest of World Antithrombin Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. CSL
  2. Octapharma AG
  3. Takeda Pharmaceutical Company Limited
  4. Grifols, S.A.
  5. Medix Biochemica
  6. Kedrion S.p.A.
  7. Scripps Laboratories
  8. LFB

Read Less

List of Figures

Figure 1: Global Antithrombin Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034

Figure 2: Global Antithrombin Market Value Share (%), by Source, 2025 & 2034

Figure 3: Global Antithrombin Market Value Share (%), by Dosage Form, 2025 & 2034

Figure 4: Global Antithrombin Market Value Share (%), by Application, 2025 & 2034

Figure 5: Global Antithrombin Market Value Share (%), by End User, 2025 & 2034

Figure 6: Global Antithrombin Market Value (USD million), by Region, 2025 & 2034

Figure 7: North America Antithrombin Market Value (USD million), by Source, 2025 & 2034

Figure 8: North America Antithrombin Market Value Share (%), by Source, 2025

Figure 9: North America Antithrombin Market Value (USD million), by Dosage Form, 2025 & 2034

Figure 10: North America Antithrombin Market Value Share (%), by Dosage Form, 2025

Figure 11: North America Antithrombin Market Value (USD million), by Application, 2025 & 2034

Figure 12: North America Antithrombin Market Value Share (%), by Application, 2025

Figure 13: North America Antithrombin Market Value (USD million), by End User, 2025 & 2034

Figure 14: North America Antithrombin Market Value Share (%), by End User, 2025

Figure 15: North America Antithrombin Market Value (USD million), By Country, 2025 & 2034

Figure 16: North America Antithrombin Market Value Share (%), By Country, 2025

Figure 17: Europe Antithrombin Market Value (USD million), by Source, 2025 & 2034

Figure 18: Europe Antithrombin Market Value Share (%), by Source, 2025

Figure 19: Europe Antithrombin Market Value (USD million), by Dosage Form, 2025 & 2034

Figure 20: Europe Antithrombin Market Value Share (%), by Dosage Form, 2025

Figure 21: Europe Antithrombin Market Value (USD million), by Application, 2025 & 2034

Figure 22: Europe Antithrombin Market Value Share (%), by Application, 2025

Figure 23: Europe Antithrombin Market Value (USD million), by End User, 2025 & 2034

Figure 24: Europe Antithrombin Market Value Share (%), by End User, 2025

Figure 25: Europe Antithrombin Market Value (USD million), By Country/ Sub-region, 2025 & 2034

Figure 26: Europe Antithrombin Market Value Share (%), By Country/ Sub-region, 2025

Figure 27: Asia Pacific Antithrombin Market Value (USD million), by Source, 2025 & 2034

Figure 28: Asia Pacific Antithrombin Market Value Share (%), by Source, 2025

Figure 29: Asia Pacific Antithrombin Market Value (USD million), by Dosage Form, 2025 & 2034

Figure 30: Asia Pacific Antithrombin Market Value Share (%), by Dosage Form, 2025

Figure 31: Asia Pacific Antithrombin Market Value (USD million), by Application, 2025 & 2034

Figure 32: Asia Pacific Antithrombin Market Value Share (%), by Application, 2025

Figure 33: Asia Pacific Antithrombin Market Value (USD million), by End User, 2025 & 2034

Figure 34: Asia Pacific Antithrombin Market Value Share (%), by End User, 2025

Figure 35: Asia Pacific Antithrombin Market Value (USD million), By Country/ Sub-region, 2025 & 2034

Figure 36: Asia Pacific Antithrombin Market Value Share (%), By Country/ Sub-region, 2025

Figure 37: Rest of the World Antithrombin Market Value (USD million), by Source, 2025 & 2034

Figure 38: Rest of the World Antithrombin Market Value Share (%), by Source, 2025

Figure 39: Rest of the World Antithrombin Market Value (USD million), by Dosage Form, 2025 & 2034

Figure 40: Rest of the World Antithrombin Market Value Share (%), by Dosage Form, 2025

Figure 41: Rest of the World Antithrombin Market Value (USD million), by Application, 2025 & 2034

Figure 42: Rest of the World Antithrombin Market Value Share (%), by Application, 2025

Figure 43: Rest of the World Antithrombin Market Value (USD million), by End User, 2025 & 2034

Figure 44: Rest of the World Antithrombin Market Value Share (%), by End User, 2025

Figure 45: Global Antithrombin Market Share (%), By Company, 2025

List of Tables

Table 1: Global Antithrombin Market Revenue (USD million) Forecast, by Source, 2021–2034

Table 2: Global Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2021–2034

Table 3: Global Antithrombin Market Revenue (USD million) Forecast, by Application, 2021–2034

Table 4: Global Antithrombin Market Revenue (USD million) Forecast, by End User, 2021–2034

Table 5: Global Antithrombin Market Revenue (USD million) Forecast, by Region, 2021-2034

Table 6: North America Antithrombin Market Revenue (USD million) Forecast, by Source, 2021-2034

Table 7: North America Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2021-2034

Table 8: North America Antithrombin Market Revenue (USD million) Forecast, by Application, 2021-2034

Table 9: North America Antithrombin Market Revenue (USD million) Forecast, by End User, 2021-2034

Table 10: North America Antithrombin Market Revenue (USD million) Forecast, By Country, 2021-2034

Table 11: Europe Antithrombin Market Revenue (USD million) Forecast, by Source, 2021-2034

Table 12: Europe Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2021-2034

Table 13: Europe Antithrombin Market Revenue (USD million) Forecast, by Application, 2021-2034

Table 14: Europe Antithrombin Market Revenue (USD million) Forecast, by End User, 2021-2034

Table 15: Europe Antithrombin Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

Table 16: Asia Pacific Antithrombin Market Revenue (USD million) Forecast, by Source, 2021-2034

Table 17: Asia Pacific Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2021-2034

Table 18: Asia Pacific Antithrombin Market Revenue (USD million) Forecast, by Application, 2021-2034

Table 19: Asia Pacific Antithrombin Market Revenue (USD million) Forecast, by End User, 2021-2034

Table 20: Asia Pacific Antithrombin Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

Table 21: Rest of the World Antithrombin Market Revenue (USD million) Forecast, by Source, 2021-2034

Table 22: Rest of the World Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2021-2034

Table 23: Rest of the World Antithrombin Market Revenue (USD million) Forecast, by Application, 2021-2034

Table 24: Rest of the World Antithrombin Market Revenue (USD million) Forecast, by End User, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 123

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com